Longboard Pharmaceuticals Q1 EPS $(0.42) Beats $(0.52) Estimate
Portfolio Pulse from Benzinga Newsdesk
Longboard Pharmaceuticals (NASDAQ:LBPH) reported Q1 earnings with losses of $(0.42) per share, surpassing the analyst consensus estimate of $(0.52) by 19.23%. This represents a 25% improvement over last year's losses of $(0.56) per share.
May 02, 2024 | 8:28 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Longboard Pharmaceuticals reported a smaller than expected loss per share in Q1, indicating a 25% improvement over the previous year.
Beating earnings estimates typically leads to positive investor sentiment, which can drive the stock price up in the short term. The 25% improvement in losses year-over-year further strengthens the case for a positive outlook on LBPH's financial health and operational efficiency.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100